Diisopropylethylamine → (2R,3R)-3-(tert-butoxy)-2-((6-fluoro-2-(((S)-1-(1-(4-fluorophenyl)-1H-pyrazol-4-yl)ethyl)amino)pyrimidin-4-yl)amino)butan-1-ol

HRID 57475

Reaktionsgleichung

Reaktionsgleichung von HRID 57475
F[C:2]1[CH:7]=[C:6]([F:8])[N:5]=[C:4]([NH:9][C@H:10]([C:12]2[CH:13]=[N:14][N:15]([C:17]3[CH:22]=[CH:21][C:20]([F:23])=[CH:19][CH:18]=3)[CH:16]=2)[CH3:11])[N:3]=1.[NH2:24][C@@H:25]([C@H:28]([O:30][C:31]([CH3:34])([CH3:33])[CH3:32])[CH3:29])[CH2:26][OH:27].C(N(C(C)C)C(C)C)C>CS(C)=O.C(OCC)(=O)C.[Cl-].[Na+]>[C:31]([O:30][C@H:28]([CH3:29])[C@H:25]([NH:24][C:2]1[CH:7]=[C:6]([F:8])[N:5]=[C:4]([NH:9][C@H:10]([C:12]2[CH:13]=[N:14][N:15]([C:17]3[CH:22]=[CH:21][C:20]([F:23])=[CH:19][CH:18]=3)[CH:16]=2)[CH3:11])[N:3]=1)[CH2:26][OH:27])([CH3:34])([CH3:32])[CH3:33]

Komponenten

7

Edukt 3

HCID 81531DiisopropylethylamineHCID 87698345(2R,3R)-2-amino-3-(tert-butoxy)butan-1-olHCID 90414038(S)-4,6-difluoro-N-(1-(1-(4-fluorophenyl)-1H-pyrazol-4-yl)ethyl)pyrimidin-2-amine

Produkt 1

HCID 90416255(2R,3R)-3-(tert-butoxy)-2-((6-fluoro-2-(((S)-1-(1-(4-fluorophenyl)-1H-pyrazol-4-yl)ethyl)amino)pyrimidin-4-yl)amino)butan-1-olAusbeute 50,4 %

Reagenzien, Katalysatoren, Lösungsmittel 3

HCID 679Dimethyl SulfoxideLösungsmittelHCID 5234Sodium ChlorideLösungsmittelHCID 8857Ethyl AcetateLösungsmittel

Versuchsvorschrift

A solution of (S)-4,6-difluoro-N-(1-(1-(4-fluorophenyl)-1H-pyrazol-4-yl)ethyl)pyrimidin-2-amine (80 mg, 0.25 mmol), (2R,3R)-2-amino-3-(tert-butoxy)butan-1-ol (55 mg, 0.28 mmol, 1.1 equiv), and N-ethyl-N-isopropylpropan-2-amine (0.11 mL, 0.63 mmol, 2.5 equiv) in DMSO (1.3 mL) was heated at 85° C. for 16 hours. The reaction was cooled to room temperature and diluted with ethyl acetate (30 mL) and dilute aqueous sodium chloride (30 mL). The layers were separated and the aqueous layer was extracted with ethyl acetate (20 mL). The combined organic extracts were dried over Na2SO4, filtered and concentrated. Silica gel column chromatography (EtOAc/Heptane) provided (2R,3R)-3-(tert-butoxy)-2-((6-fluoro-2-(((S)-1-(1-(4-fluorophenyl)-1H-pyrazol-4-yl)ethyl)amino)pyrimidin-4-yl)amino)butan-1-ol (0.058 g, white solid) in 50% yield. 1H NMR (400 MHz, CDCl3) δ 7.79 (s, 1H), 7.66 (s, 1H), 7.61 (m, 2H), 7.13 (t, J=8.6 Hz, 2H), 5.35 (s, 1H), 5.30-5.14 (m, 2H), 5.04 (m, 1H), 3.94 (m, 1H), 3.77-3.65 (m, 2H), 1.57 (d, J=6.9 Hz, 3H), 1.21 (s, 9H), 1.15 (d, J=6.0 Hz, 3H). MS m/z 461.3 (M+H)+; Rt-0.88 min.

Aufarbeitung

  1. customThe layers were separated
  2. extractionthe aqueous layer was extracted with ethyl acetate (20 mL)
  3. dry with materialThe combined organic extracts were dried over Na2SO4
  4. filtrationfiltered
  5. concentrationconcentrated

Quellen und Nachweise

ORD-Eintrag
ord-017e1f87c813466585d0d3d9e2e4e694
Quelldatensatz
uspto-grants-2016_09
Patentnummer
US09434719B2

Verknüpfte Notizen

Wird geladen…